160 related articles for article (PubMed ID: 9065350)
1. One year follow-up of patients with rhinitis medicamentosa after vasoconstrictor withdrawal.
Graf PM; Hallén H
Am J Rhinol; 1997; 11(1):67-72. PubMed ID: 9065350
[TBL] [Abstract][Full Text] [Related]
2. One-week use of oxymetazoline nasal spray in patients with rhinitis medicamentosa 1 year after treatment.
Graf P; Hallén H
ORL J Otorhinolaryngol Relat Spec; 1997; 59(1):39-44. PubMed ID: 9104748
[TBL] [Abstract][Full Text] [Related]
3. Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity.
Graf P
Rhinology; 1996 Mar; 34(1):9-13. PubMed ID: 8739860
[TBL] [Abstract][Full Text] [Related]
4. Correlation between objective nasal mucosal swelling and estimated stuffiness during long-term use of vasoconstrictors.
Graf P; Juto JE
ORL J Otorhinolaryngol Relat Spec; 1994; 56(6):334-9. PubMed ID: 7530821
[TBL] [Abstract][Full Text] [Related]
5. [Ultrastructural changes in human nasal mucosa in rhinitis medicamentosa].
Knipping S; Holzhausen HJ; Riederer A; Bloching M
HNO; 2006 Oct; 54(10):742-8. PubMed ID: 16477462
[TBL] [Abstract][Full Text] [Related]
6. The pathophysiology and treatment of rhinitis medicamentosa.
Graf P; Hallén H; Juto JE
Clin Otolaryngol Allied Sci; 1995 Jun; 20(3):224-9. PubMed ID: 7554332
[TBL] [Abstract][Full Text] [Related]
7. Effect on the nasal mucosa of long-term treatment with oxymetazoline, benzalkonium chloride, and placebo nasal sprays.
Graf P; Hallén H
Laryngoscope; 1996 May; 106(5 Pt 1):605-9. PubMed ID: 8628089
[TBL] [Abstract][Full Text] [Related]
8. Sustained use of xylometazoline nasal spray shortens the decongestive response and induces rebound swelling.
Graf P; Juto JE
Rhinology; 1995 Mar; 33(1):14-7. PubMed ID: 7540314
[TBL] [Abstract][Full Text] [Related]
9. Rhinitis medicamentosa: aspects of pathophysiology and treatment.
Graf P
Allergy; 1997; 52(40 Suppl):28-34. PubMed ID: 9353558
[TBL] [Abstract][Full Text] [Related]
10. [Rhinitis medicamentosa in cytological assessment of the nasal mucosa].
Tarchalska B; Gotlib T; Samoliński B
Pol Merkur Lekarski; 2005 Sep; 19(111):288-90. PubMed ID: 16358845
[TBL] [Abstract][Full Text] [Related]
11. [Tolerance and effectiveness of oxymetazoline and xylometazoline in treatment of acute rhinitis].
Dorn M; Hofmann W; Knick E
HNO; 2003 Oct; 51(10):794-9. PubMed ID: 14523532
[TBL] [Abstract][Full Text] [Related]
12. [The rebound of nasal resistance after decongestant used in nose].
Shen J; Huang X; Xiang J; Shu H
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1999 Dec; 13(12):560-1. PubMed ID: 12541428
[TBL] [Abstract][Full Text] [Related]
13. Benzalkonium chloride in a decongestant nasal spray aggravates rhinitis medicamentosa in healthy volunteers.
Graf P; Hallén H; Juto JE
Clin Exp Allergy; 1995 May; 25(5):395-400. PubMed ID: 7553241
[TBL] [Abstract][Full Text] [Related]
14. Four-week use of oxymetazoline nasal spray (Nezeril) once daily at night induces rebound swelling and nasal hyperreactivity.
Graf P; Hallén H; Juto JE
Acta Otolaryngol; 1995 Jan; 115(1):71-5. PubMed ID: 7762389
[TBL] [Abstract][Full Text] [Related]
15. Xylitol treats nasal mucosa in rhinitis medicamentosa: an experimental rat model study.
Cam B; Sari M; Midi A; Gergin O
Eur Arch Otorhinolaryngol; 2019 Nov; 276(11):3123-3130. PubMed ID: 31468129
[TBL] [Abstract][Full Text] [Related]
16. Rhinitis medicamentosa: a review of causes and treatment.
Graf P
Treat Respir Med; 2005; 4(1):21-9. PubMed ID: 15725047
[TBL] [Abstract][Full Text] [Related]
17. ["Of snakes and crocodiles": central side effects of nose drops and facts about rhinitis medicamentosa].
Bielenberg J
Kinderkrankenschwester; 2011 Oct; 30(10):406-8. PubMed ID: 22029138
[No Abstract] [Full Text] [Related]
18. An evaluation of nasal response following different treatment regimes of oxymetazoline with reference to rebound congestion.
Morris S; Eccles R; Martez SJ; Riker DK; Witek TJ
Am J Rhinol; 1997; 11(2):109-15. PubMed ID: 9129752
[TBL] [Abstract][Full Text] [Related]
19. Changes in nasal reactivity in patients with rhinitis medicamentosa after treatment with fluticasone propionate and placebo nasal spray.
Graf PM; Hallén H
ORL J Otorhinolaryngol Relat Spec; 1998; 60(6):334-8. PubMed ID: 9742282
[TBL] [Abstract][Full Text] [Related]
20. Fluticasone propionate nasal spray is more effective and has a faster onset of action than placebo in treatment of rhinitis medicamentosa.
Hallén H; Enerdal J; Graf P
Clin Exp Allergy; 1997 May; 27(5):552-8. PubMed ID: 9179430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
